Urotensin-II and the cardiovascular system – the importance of developing modulators

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.5, 2004-05, pp. : 479-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-peptidic urotensin-II receptor modulators

By Jin Jian   Douglas Stephen A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 467-479

Informa Healthcare

Access to resources Recommend Favorite

Emerging Role of the Urotensin II System in Cardiovascular Disease

By  

Heart Drug, Vol. 3, Iss. 3, 2003-11 ,pp. : 153-158

Karger

Access to resources Recommend Favorite

Urotensin-II Receptor Antagonists

By  

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 267-275

Bentham Science Publishers

Access to resources Recommend Favorite

Urotensin-II: a novel systemic hypertensive factor in the cat

By Behm David   Doe Christopher   Johns Douglas   Maniscalco Kristeen   Stankus Gerald   Wibberley Alexandra   Willette Robert   Douglas Stephen  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 3, 2004-03 ,pp. : 274-280

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular actions of human urotensin II—considerations for hypertension

By Russell Fraser   Molenaar Peter  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 3, 2004-03 ,pp. : 271-273

Springer Publishing Company

Access to resources Recommend Favorite